GOLDMAN SACHS GROUP INC
Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.
CIK 886982
NEW YORK, NY
Position in CRBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$589,654
-$284,657 QoQ
Shares Held
62,863
-32.5% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 106 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBP Over Time
Shares Held
Position Value (USD)
Derivatives in CRBP
reported options exposure · as of Sep 30, 2020CallValue
$143,819
CallShares
2,663
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. CRBP ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CRBP
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $589,654 | 62,863 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $874,311 | 93,111 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $386,145 | 47,438 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $421,902 | 33,352 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $301,350 | 43,674 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $307,639 | 57,936 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $674,653 | 57,174 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,019,534 | 49,420 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,738,892 | 60,528 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,174,272 | 106,378 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $14,616 | 88,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,125 | 95,738 | Shares | Defined | 2022-08-18 | |
| 2021-12-31 | $52,661 | 85,491 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $159,854 | 156,720 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $112,570 | 61,514 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $423,492 | 214,971 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $76,019 | 60,816 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $143,819 | 79,900 | Call | Defined | 2020-11-13 | |
| 2020-09-30 | $199,534 | 110,853 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $579,027 | 69,014 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $378,181 | 72,172 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||